Luxottica: Bryan Garnier still a buyer.
(CercleFinance.com) - Bryan Garnier has reiterated its "buy" rating on the Luxottica stock, along with a fair value of 64 euros, highlighting an improved momentum in the US (around 56% of sales).
As catalysts, the broker also underlines more dynamic sales and earnings growth in H2, in addition to its successful merger with Essilor, benefiting from reasonable multiples.
Furthermore, the broker says “we remain convinced that the EI and LUX teams will work hard to convince their customers of the benefits of this combination in terms of level of service, choice and speed to market.”
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
As catalysts, the broker also underlines more dynamic sales and earnings growth in H2, in addition to its successful merger with Essilor, benefiting from reasonable multiples.
Furthermore, the broker says “we remain convinced that the EI and LUX teams will work hard to convince their customers of the benefits of this combination in terms of level of service, choice and speed to market.”
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.